Helmintox (Pyrantel)

Helmintox is indicated for the treatment of several common intestinal nematode infections.

• Ascariasis (infection with Ascaris lumbricoides)
• Enterobiasis (pinworm infection caused by Enterobius vermicularis)
• Hookworm infection (Ancylostoma duodenale or Necator americanus)
• Other susceptible nematode infections as determined by a healthcare professional
• Prophylactic use in endemic areas may be considered under medical guidance

Side effects reported with pyrantel are generally mild, but serious reactions can occur in rare cases. These effects are typically transient and resolve without medical intervention.

Common

• Nausea
• Abdominal discomfort or pain
• Diarrhea
• Vomiting
• Headache
• Mild skin rash
• Dizziness
• Fatigue

Serious

• Severe allergic reaction (anaphylaxis)
• Persistent abdominal pain
• Severe vomiting
• Hepatic dysfunction
• Blood dyscrasias
• Seizures (rare)

Before using Helmintox, certain precautions should be considered to ensure safe and effective treatment.

• Confirm diagnosis of a nematode infection before initiating therapy.
• Do not use in individuals with known hypersensitivity to pyrantel or any formulation components.
• Pregnancy and lactation status are not well established; consult a healthcare professional.
• Use caution in patients with hepatic impairment or severe liver disease.
• Pediatric dosing should follow age‑specific guidelines; not recommended for infants under two months.
• Ensure proper hydration to facilitate gastrointestinal clearance.
• Avoid use in patients taking other neuromuscular‑blocking agents without medical advice.

Helmintox may interact with other medicines; awareness of potential interactions helps avoid reduced efficacy or increased toxicity.

Avoid

• Concurrent use with other anthelmintic agents unless directed by a clinician.
• Combination with strong cholinesterase inhibitors (e.g., pyridostigmine) may enhance neuromuscular effects.

Use with caution

• Antacids or acid‑reducing agents that may alter gastric pH and affect absorption.
• Warfarin or other anticoagulants, as rare reports suggest altered INR.
• Drugs metabolized by hepatic enzymes (e.g., CYP3A4 substrates) may require monitoring.
• Herbal supplements such as St. John’s wort that induce hepatic enzymes.